Brian Feagan, Director of Robarts Clinical Trials at Robarts Study Institute at The University of Western Ontario. Dr infecciones-del-tracto-respiratorio.html . Feagan coordinated the extensive analysis trial and is an author on the study. It’s simply a safer, more effective treatment method. The choice strategy, called ‘top-down’ therapy, employs early usage of immune-suppressing drugs combined with an antibody in order to address the disease right away. Symptom-treating steroids may never be needed.